NCT06852950View on ClinicalTrials.gov

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 9, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus (T1DM)Hyperglycemia
Interventions
DEVICE

Libre 3 Plus Continuous Glucose Monitor

Subjects in this arm will start using the Libre 3 Plus continuous glucose monitor.

DEVICE

Dexcom G7 Continuous Glucose Monitor

Subjects in this arm will start using the Dexcom G7 continuous glucose monitor.

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER